Amazon Q Developer is a useful AI-powered coding assistant with chat, CLI, Model Context Protocol and agent support, and AWS ...

Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized ...

The original version of this story appeared in Quanta Magazine. Imagine that someone gives you a list of five numbers: 1, 6, 21, 107, and—wait for it—47,176,870. Can you guess what comes next? If ...

Google Flights is getting an AI tool to help you find the best deals for your upcoming trips by just going to a chatbox and telling it what you want. Called Flight Deals, you use it just like you'd ...

There was a time when your landline phone would ring and you automatically answered without knowing who was calling. Today, the introduction of cell phones, voicemail, and caller ID has allowed us to ...

Deep beneath Utah’s desert soil, an oil drill bored through the Earth at a blistering pace earlier this spring. Gnarly looking drill bits tore through granite at around 300 feet per hour. It was done ...

The adoption of artificial intelligence (AI) in U.S. classrooms has accelerated rapidly over the past year, with double-digit growth in the number of students using AI tools for schoolwork, according ...

Ms. O’Rourke is the executive editor of The Yale Review and a professor of creative writing at Yale University. July 18, 2025 When I first told ChatGPT who I was, it sent a gushing reply: “Oh wow — it ...

For this week’s Open Questions column, Dhruv Khullar is filling in for Joshua Rothman. When David Fajgenbaum was a twenty-five-year-old medical student, at the University of Pennsylvania, he started ...

– Company Eligible to Receive Up to $25 Million, Including an Upfront Equity Payment of $7.5 Million – – Extends Rallybio Cash Runway to Mid-2027 – NEW HAVEN, Conn.--(BUSINESS WIRE)-- Rallybio ...

Recursion, a clinical-stage TechBio company, has successfully acquired Rallybio’s entire interest in their joint ENPP1 inhibitor program (REV102) aimed at treating hypophosphatasia (HPP), a rare ...